Stock Comparison

ARGX vs KYMR

argenx NV ADR and Kymera Therapeutics Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

KYMR

Kymera Therapeutics Inc

Healthcare

Valuation

Market Cap

$53.23B

$9.32B

P/E (TTM)

32.7

—

Forward P/E

30.4

—

Price/Sales

10.0

88.8

Price/Book

6.4

6.3

EV/EBITDA

27.6

-10.0

Dividend Yield

—

Profitability

Net Margin

30.44%

-612.17%

Operating Margin

27.34%

-697.81%

Return on Equity

23.60%

-24.10%

Return on Assets

11.60%

-15.60%

Growth (YoY)

Revenue Growth

59.30%

466.40%

Earnings Growth

95.20%

0.00%

Price & Risk

Beta

-0.0

2.0

52-Week High

$939.68

$119.35

52-Week Low

$652.43

$40.69

Analyst Target

$1,085.78

$131.00

Compare ARGX and KYMR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.